Page last updated: 2024-10-21

urea and Hepatocellular Carcinoma

urea has been researched along with Hepatocellular Carcinoma in 87 studies

pseudourea: clinical use; structure
isourea : A carboximidic acid that is the imidic acid tautomer of urea, H2NC(=NH)OH, and its hydrocarbyl derivatives.

Research Excerpts

ExcerptRelevanceReference
"The aim of this study is validated the prophylactic efficacy of urea-based creams on sorafenib-induced hand-foot skin reaction in patients with advanced hepatocellular carcinoma."9.51Validation of the prophylactic efficacy of urea-based creams on sorafenib-induced hand-foot skin reaction in patients with advanced hepatocellular carcinoma: A randomised experiment study. ( Hu, SH; Lien, RY; Lu, LC; Lu, SF; Tung, HH; Wu, SL, 2022)
"Hand-foot skin reaction (HFSR) is the most common adverse event during sorafenib treatment in patients with hepatocellular carcinoma (HCC)."9.34Effect of urea cream on sorafenib-associated hand-foot skin reaction in patients with hepatocellular carcinoma: A multicenter, randomised, double-blind controlled study. ( Cho, SB; Hong, YM; Hwang, SY; Jang, BK; Jang, ES; Jang, JY; Jung, YK; Kim, DY; Kim, HJ; Kim, JH; Kim, MY; Lee, HW; Lee, JH; Lee, YS; Seo, YS; Yim, HJ; Yoon, KT, 2020)
"To assess whether urea-based cream (UBC) has prophylactic benefits on sorafenib-induced hand-foot skin reaction (HFSR) in patients with advanced hepatocellular carcinoma (HCC)."9.20Randomized controlled trial of the prophylactic effect of urea-based cream on sorafenib-associated hand-foot skin reactions in patients with advanced hepatocellular carcinoma. ( Bai, Y; Guo, X; Kang, H; Lu, L; Lu, M; Qu, Z; Ren, Z; Shi, L; Song, T; Wang, H; Wang, X; Yang, W; Yang, Y; Ye, SL; Zhou, W; Zhu, K, 2015)
" RESULTS In the mouse model of NAFLD, RKI-1447 reduced insulin resistance and the levels of alanine aminotransferase (ALT), aspartate transaminase (AST), total cholesterol, triglyceride, interleukin-6 (IL-6), tumor necrosis factor-alpha (TNF-alpha), malondialdehyde (MDA), and superoxide dismutase (SOD)."7.96The Effects of RKI-1447 in a Mouse Model of Nonalcoholic Fatty Liver Disease Induced by a High-Fat Diet and in HepG2 Human Hepatocellular Carcinoma Cells Treated with Oleic Acid. ( Jiang, W; Wang, J, 2020)
"In our effort to develop potent and effective agents with anti-proliferative activity towards HepG2 hepatocellular carcinoma cells with potential inhibitory activity against VEGFR-2, a novel series of 1-(4-((2-oxoindolin-3-ylidene)amino)phenyl)-3-arylureas was designed and synthesized."7.81Indoline ureas as potential anti-hepatocellular carcinoma agents targeting VEGFR-2: Synthesis, in vitro biological evaluation and molecular docking. ( Abdel-Aziz, HA; Abou El Ella, DA; Abou-Seri, SM; Ali, MM; Aly, MH; Eldehna, WM; Fares, M; Ibrahim, HS; Zada, S, 2015)
"The aim of this study is validated the prophylactic efficacy of urea-based creams on sorafenib-induced hand-foot skin reaction in patients with advanced hepatocellular carcinoma."5.51Validation of the prophylactic efficacy of urea-based creams on sorafenib-induced hand-foot skin reaction in patients with advanced hepatocellular carcinoma: A randomised experiment study. ( Hu, SH; Lien, RY; Lu, LC; Lu, SF; Tung, HH; Wu, SL, 2022)
"In this report, we show that human hepatocellular carcinoma (HCC) cells do not express CPS1, whereas cultured human primary hepatocytes express abundant levels."5.37DNA methylation suppresses expression of the urea cycle enzyme carbamoyl phosphate synthetase 1 (CPS1) in human hepatocellular carcinoma. ( Dong, H; Liu, C; Liu, H; Robertson, K, 2011)
"Hand-foot skin reaction (HFSR) is the most common adverse event during sorafenib treatment in patients with hepatocellular carcinoma (HCC)."5.34Effect of urea cream on sorafenib-associated hand-foot skin reaction in patients with hepatocellular carcinoma: A multicenter, randomised, double-blind controlled study. ( Cho, SB; Hong, YM; Hwang, SY; Jang, BK; Jang, ES; Jang, JY; Jung, YK; Kim, DY; Kim, HJ; Kim, JH; Kim, MY; Lee, HW; Lee, JH; Lee, YS; Seo, YS; Yim, HJ; Yoon, KT, 2020)
"To assess whether urea-based cream (UBC) has prophylactic benefits on sorafenib-induced hand-foot skin reaction (HFSR) in patients with advanced hepatocellular carcinoma (HCC)."5.20Randomized controlled trial of the prophylactic effect of urea-based cream on sorafenib-associated hand-foot skin reactions in patients with advanced hepatocellular carcinoma. ( Bai, Y; Guo, X; Kang, H; Lu, L; Lu, M; Qu, Z; Ren, Z; Shi, L; Song, T; Wang, H; Wang, X; Yang, W; Yang, Y; Ye, SL; Zhou, W; Zhu, K, 2015)
" AQP3 is involved in the diarrhea and inflammatory bowel disease; AQP5 is relevant to gastric carcinoma cell proliferation and migration; AQP9 plays considerable role in glycerol metabolism , urea transport and hepatocellular carcinoma."4.95Aquaporins in Digestive System. ( Mei, Z; Ran, J; Yang, B; Zhu, S, 2017)
"We aimed to determine the association between blood urea level and incident cirrhosis, hepatic decompensation, and hepatocellular carcinoma in chronic liver disease (CLD) patients."4.12U-shaped relationship between urea level and hepatic decompensation in chronic liver diseases. ( Chan, HL; Hui, VW; Lai, JC; Lin, H; Liu, K; Tse, YK; Wong, GL; Wong, VW; Yip, TC; Zhang, X, 2022)
" RESULTS In the mouse model of NAFLD, RKI-1447 reduced insulin resistance and the levels of alanine aminotransferase (ALT), aspartate transaminase (AST), total cholesterol, triglyceride, interleukin-6 (IL-6), tumor necrosis factor-alpha (TNF-alpha), malondialdehyde (MDA), and superoxide dismutase (SOD)."3.96The Effects of RKI-1447 in a Mouse Model of Nonalcoholic Fatty Liver Disease Induced by a High-Fat Diet and in HepG2 Human Hepatocellular Carcinoma Cells Treated with Oleic Acid. ( Jiang, W; Wang, J, 2020)
" Among these analogues, 3y exhibited a better cytotoxic effect on human hepatocellular carcinoma (HCC) Hep 3B cells and displayed less cytotoxicity on normal human umbilical vein endothelial cells, compared with Sorafenib, a targeted therapy for advanced HCC."3.85Using gene expression database to uncover biology functions of 1,4-disubstituted 1,2,3-triazole analogues synthesized via a copper (I)-catalyzed reaction. ( Huang, CF; Liu, HS; Ramesh, C; Su, CL; Tseng, CL; Yao, CF, 2017)
"In our effort to develop potent and effective agents with anti-proliferative activity towards HepG2 hepatocellular carcinoma cells with potential inhibitory activity against VEGFR-2, a novel series of 1-(4-((2-oxoindolin-3-ylidene)amino)phenyl)-3-arylureas was designed and synthesized."3.81Indoline ureas as potential anti-hepatocellular carcinoma agents targeting VEGFR-2: Synthesis, in vitro biological evaluation and molecular docking. ( Abdel-Aziz, HA; Abou El Ella, DA; Abou-Seri, SM; Ali, MM; Aly, MH; Eldehna, WM; Fares, M; Ibrahim, HS; Zada, S, 2015)
" Here, we report the effect of an APN inhibitor 4cc in enhancing sensitivity of hepatocellular carcinoma (HCC) cell lines and xenograft model in response to 5-fluorouracil (5-FU) in vivo and in vitro."3.81Aminopeptidase N inhibitor 4cc synergizes antitumor effects of 5-fluorouracil on human liver cancer cells through ROS-dependent CD13 inhibition. ( Dai, G; Duan, Y; Shi, LH; Sun, ZP; Wang, XJ; Xu, WF; Zhang, J; Zhang, XR, 2015)
"The rates of urea synthesis in rat liver and in a series of rat liver neoplasms with widely different growth rates and degree of differentiation were investigated using tissue slices incubated in a Krebs-Ringer bicarbonate buffer."3.65Urea synthesis in Novikoff and Morris hepatomas. ( Lawson, D; Morris, HP; Paik, WK; Weinhouse, S, 1977)
"The purpose of this Functional Imaging Liver Cancer (FLIC) trial is to assess the ability of 18F-DCFPyL-PET/CT to detect sites of HCC."3.11Functional Imaging of Liver Cancer (FLIC): Study protocol of a phase 2 trial of 18F-DCFPyL PET/CT imaging for patients with hepatocellular carcinoma. ( Choyke, PL; Chung, JY; Escorcia, FE; Hernandez, J; Jakhete, N; Jones, J; Kassin, M; Lindenberg, L; Maass-Moreno, R; Mena, E; Molitoris, JK; Monge, C; Rabiee, A; Saboury, B; Salerno, KE; Shih, J; Turkbey, B; Unger, KR; Wood, B, 2022)
"HepG2 is a human hepatoma that is most commonly used in drug metabolism and hepatotoxicity studies."1.42Culture and Functional Characterization of Human Hepatoma HepG2 Cells. ( Donato, MT; Gómez-Lechón, MJ; Tolosa, L, 2015)
"In this report, we show that human hepatocellular carcinoma (HCC) cells do not express CPS1, whereas cultured human primary hepatocytes express abundant levels."1.37DNA methylation suppresses expression of the urea cycle enzyme carbamoyl phosphate synthetase 1 (CPS1) in human hepatocellular carcinoma. ( Dong, H; Liu, C; Liu, H; Robertson, K, 2011)
"Urea was quantified using (15)N-ammonium chloride metabolic labelling with gas chromatography-mass spectrometry."1.35Cells for bioartificial liver devices: the human hepatoma-derived cell line C3A produces urea but does not detoxify ammonia. ( Damelin, LH; Eaton, S; Hodgson, HJ; Mavri-Damelin, D; Rees, M; Selden, C, 2008)
"01), at least compatible to the inhibition by vincristine (43% inhibition), indicating good bioavailability of the compound in the circulation."1.32Inhibition of microtubule polymerization by 3-bromopropionylamino benzoylurea (JIMB01), a new cancericidal tubulin ligand. ( Bekesi, G; Holland, JF; Hu, QY; Jiang, JD; Li, JN; Lin, YH; Song, DQ; Yin, L, 2003)
"In fact, the hepatomas showed the greatest changes in response to diet."1.26Regulation of urea cycle enzymes in transplantable hepatomas and in the livers of tumor-bearing rats and humans. ( Balinsky, JB; Brebnor, LD; Grimm, J, 1981)
"Faster growing hepatomas also have greater quantities of sulfhydryls and disulfides."1.25Sulfhydryl group quantitation of hepatoma and liver microsomal fractions. ( Hochberg, AA; Morris, HP; Stratman, FW; Zahlten, RN, 1975)
"Ferritin purified from hepatoma tissue migrated slightly faster than normal human liver ferritin in polyacrylamide gel electrophoresis."1.25Characterization and subunit analysis of ferritin isolated from normal and malignant human liver. ( Alpert, E, 1975)
"In the hepatomas, evidence was obtained for the preexistence of considerable amounts of the smaller, RNase-containing subunits in the cell."1.24Studies on the function of intracellular ribonucleases. V. Ribonuclease activity in ribosomes and polysomes prepared from rat liver and hepatomas. ( Roth, JS; Utsunomiya, T, 1966)

Research

Studies (87)

TimeframeStudies, this research(%)All Research%
pre-199043 (49.43)18.7374
1990's5 (5.75)18.2507
2000's9 (10.34)29.6817
2010's17 (19.54)24.3611
2020's13 (14.94)2.80

Authors

AuthorsStudies
Lin, H1
Wong, GL1
Zhang, X5
Yip, TC1
Liu, K1
Tse, YK1
Hui, VW1
Lai, JC1
Chan, HL1
Wong, VW1
Li, J9
Shi, C1
Shi, J1
Song, J4
Wang, N1
Lien, RY1
Tung, HH1
Wu, SL1
Hu, SH1
Lu, LC1
Lu, SF1
Sugiura, S1
Satoh, T1
Shin, K1
Onuki-Nagasaki, R1
Kanamori, T1
Mena, E1
Shih, J1
Chung, JY1
Jones, J1
Rabiee, A1
Monge, C1
Turkbey, B1
Lindenberg, L1
Salerno, KE1
Kassin, M1
Wood, B1
Hernandez, J1
Maass-Moreno, R1
Saboury, B1
Jakhete, N1
Molitoris, JK1
Unger, KR1
Choyke, PL1
Escorcia, FE1
Zhang, S6
Hu, Y3
Wu, Z3
Zhou, X5
Wu, T4
Li, P4
Lian, Q3
Xu, S3
Gu, J3
Chen, L6
Wu, G4
Zhang, T5
Tang, J3
Xue, J3
Ivanova, ON1
Krasnov, GS1
Snezhkina, AV1
Kudryavtseva, AV1
Fedorov, VS1
Zakirova, NF1
Golikov, MV1
Kochetkov, SN1
Bartosch, B1
Valuev-Elliston, VT1
Ivanov, AV1
Wang, J5
Jiang, W1
Nguépy Keubo, FR1
Mboua, PC1
Djifack Tadongfack, T1
Fokouong Tchoffo, E1
Tasson Tatang, C1
Ide Zeuna, J1
Noupoue, EM1
Tsoplifack, CB1
Folefack, GO1
Kettani, M1
Bandelier, P1
Huo, J1
Li, H5
Yu, D1
Arulsamy, N1
AlAbbad, S1
Sardot, T1
Lekashvili, O1
Decato, D1
Lelj, F1
Alexander Ross, JB1
Rosenberg, E1
Nazir, H1
Muthuswamy, N1
Louis, C1
Jose, S1
Prakash, J1
Buan, MEM1
Flox, C1
Chavan, S1
Shi, X1
Kauranen, P1
Kallio, T1
Maia, G1
Tammeveski, K1
Lymperopoulos, N1
Carcadea, E1
Veziroglu, E1
Iranzo, A1
M Kannan, A1
Arunamata, A1
Tacy, TA1
Kache, S1
Mainwaring, RD1
Ma, M1
Maeda, K1
Punn, R1
Noguchi, S1
Hahn, S3
Iwasa, Y3
Ling, J2
Voccio, JP2
Kim, Y3
Bascuñán, J2
Chu, Y1
Tomita, M1
Cazorla, M1
Herrera, E1
Palomeque, E1
Saud, N1
Hoplock, LB1
Lobchuk, MM1
Lemoine, J1
Li, X10
Henson, MA1
Unsihuay, D1
Qiu, J1
Swaroop, S1
Nagornov, KO1
Kozhinov, AN1
Tsybin, YO1
Kuang, S1
Laskin, J1
Zin, NNINM1
Mohamad, MN1
Roslan, K1
Abdul Wafi, S1
Abdul Moin, NI1
Alias, A1
Zakaria, Y1
Abu-Bakar, N1
Naveed, A1
Jilani, K1
Siddique, AB1
Akbar, M1
Riaz, M1
Mushtaq, Z1
Sikandar, M1
Ilyas, S1
Bibi, I1
Asghar, A1
Rasool, G1
Irfan, M1
Li, XY1
Zhao, S1
Fan, XH1
Chen, KP1
Hua, W1
Liu, ZM1
Xue, XD1
Zhou, B1
Xing, YL1
Chen, MA1
Sun, Y1
Neradilek, MB1
Wu, XT1
Zhang, D2
Huang, W1
Cui, Y1
Yang, QQ1
Li, HW1
Zhao, XQ1
Hossein Rashidi, B1
Tarafdari, A1
Ghazimirsaeed, ST1
Shahrokh Tehraninezhad, E1
Keikha, F1
Eslami, B1
Ghazimirsaeed, SM1
Jafarabadi, M1
Silvani, Y1
Lovita, AND1
Maharani, A1
Wiyasa, IWA1
Sujuti, H1
Ratnawati, R1
Raras, TYM1
Lemin, AS1
Rahman, MM1
Pangarah, CA1
Kiyu, A1
Zeng, C2
Du, H1
Lin, D1
Jalan, D1
Rubagumya, F1
Hopman, WM1
Vanderpuye, V1
Lopes, G1
Seruga, B1
Booth, CM1
Berry, S1
Hammad, N1
Sajo, EA1
Okunade, KS1
Olorunfemi, G1
Rabiu, KA1
Anorlu, RI1
Xu, C2
Xiang, Y1
Xu, X1
Zhou, L3
Dong, X1
Tang, S1
Gao, XC1
Wei, CH1
Zhang, RG1
Cai, Q1
He, Y1
Tong, F1
Dong, JH1
Dong, XR1
Tang, X1
Tao, F1
Xiang, W1
Zhao, Y2
Jin, L1
Tao, H1
Lei, Y1
Gan, H1
Huang, Y1
Chen, Y3
Shan, A1
Zhao, H2
Wu, M2
Ma, Q1
Zhang, E1
Zhang, J5
Li, Y5
Xue, F1
Deng, L1
Liu, L2
Yan, Z2
Wang, Y2
Meng, J1
Chen, G3
Anastassiadou, M1
Bernasconi, G1
Brancato, A1
Carrasco Cabrera, L1
Greco, L1
Jarrah, S1
Kazocina, A1
Leuschner, R1
Magrans, JO1
Miron, I1
Nave, S1
Pedersen, R1
Reich, H1
Rojas, A1
Sacchi, A1
Santos, M1
Theobald, A1
Vagenende, B1
Verani, A1
Du, L1
Liu, X1
Ren, Y1
Jiao, Q1
Meng, P1
Wang, F2
Wang, YS1
Wang, C3
Wang, W1
Wang, S2
Hou, J1
Zhang, A2
Lv, B1
Gao, C1
Pang, D1
Lu, K1
Ahmad, NH1
Wang, L1
Zhu, J2
Zhang, L2
Zhuang, T1
Tu, J1
Zhao, Z1
Qu, Y1
Yao, H1
Wang, X6
Lee, DF1
Shen, J3
Wen, L1
Huang, G2
Xie, X1
Zhao, Q1
Hu, W2
Zhang, Y4
Wu, X1
Lu, J2
Li, M2
Li, W2
Wu, W1
Du, F1
Ji, H1
Yang, X2
Xu, Z1
Wan, L1
Wen, Q1
Cho, CH1
Zou, C1
Xiao, Z1
Liao, J1
Su, X1
Bi, Z1
Su, Q1
Huang, H1
Wei, Y2
Gao, Y2
Na, KJ1
Choi, H1
Oh, HR1
Kim, YH1
Lee, SB1
Jung, YJ1
Koh, J1
Park, S1
Lee, HJ1
Jeon, YK1
Chung, DH1
Paeng, JC1
Park, IK1
Kang, CH1
Cheon, GJ1
Kang, KW1
Lee, DS1
Kim, YT1
Pajuelo-Lozano, N1
Alcalá, S1
Sainz, B1
Perona, R1
Sanchez-Perez, I1
Logotheti, S1
Marquardt, S1
Gupta, SK1
Richter, C1
Edelhäuser, BAH1
Engelmann, D1
Brenmoehl, J1
Söhnchen, C1
Murr, N1
Alpers, M1
Singh, KP1
Wolkenhauer, O1
Heckl, D1
Spitschak, A1
Pützer, BM1
Liao, Y1
Cheng, J1
Kong, X1
Li, S1
Zhang, M4
Zhang, H1
Yang, T2
Dong, Y1
Xu, Y1
Yuan, Z1
Cao, J1
Zheng, Y1
Luo, Z1
Mei, Z2
Yao, Y1
Liu, Z2
Liang, C1
Yang, H2
Song, Y1
Yu, K1
Zhu, C1
Huang, Z1
Qian, J1
Ge, J1
Hu, J2
Wang, H4
Liu, Y4
Mi, Y1
Kong, H1
Xi, D1
Yan, W1
Luo, X1
Ning, Q1
Chang, X2
Wang, Q2
Rathore, MG1
Reddy, K1
Chen, H2
Shin, SH1
Ma, WY1
Bode, AM1
Dong, Z1
Mu, W1
Liu, C4
Gao, F1
Qi, Y1
Lu, H1
Cai, X1
Ji, RY1
Hou, Y3
Tian, J2
Shi, Y1
Ying, S1
Tan, M1
Feng, G1
Kuang, Y1
Chen, D1
Wu, D3
Zhu, ZQ1
Tang, HX1
Shi, ZE1
Kang, J1
Liu, Q1
Qi, J2
Mu, J1
Cong, Z1
Chen, S2
Fu, D1
Li, Z3
Celestrin, CP1
Rocha, GZ1
Stein, AM1
Guadagnini, D1
Tadelle, RM1
Saad, MJA1
Oliveira, AG1
Bianconi, V1
Bronzo, P1
Banach, M1
Sahebkar, A1
Mannarino, MR1
Pirro, M1
Patsourakos, NG1
Kouvari, M1
Kotidis, A1
Kalantzi, KI1
Tsoumani, ME1
Anastasiadis, F1
Andronikos, P1
Aslanidou, T1
Efraimidis, P1
Georgiopoulos, A1
Gerakiou, K1
Grigoriadou-Skouta, E1
Grigoropoulos, P1
Hatzopoulos, D1
Kartalis, A1
Lyras, A1
Markatos, G1
Mikrogeorgiou, A1
Myroforou, I1
Orkopoulos, A1
Pavlidis, P1
Petras, C1
Riga, M1
Skouloudi, M1
Smyrnioudis, N1
Thomaidis, K1
Tsikouri, GE1
Tsikouris, EI1
Zisimos, K1
Vavoulis, P1
Vitali, MG1
Vitsas, G1
Vogiatzidis, C1
Chantanis, S1
Fousas, S1
Panagiotakos, DB1
Tselepis, AD1
Jungen, C1
Alken, FA1
Eickholt, C1
Scherschel, K1
Kuklik, P1
Klatt, N1
Schwarzl, J1
Moser, J1
Jularic, M1
Akbulak, RO1
Schaeffer, B1
Willems, S1
Meyer, C1
Nowak, JK1
Szczepanik, M1
Trypuć, M1
Pogorzelski, A1
Bobkowski, W1
Grytczuk, M1
Minarowska, A1
Wójciak, R1
Walkowiak, J1
Lu, Y1
Xi, J1
Li, C1
Chen, W2
Hu, X1
Zhang, F1
Wei, H1
Wang, Z2
Gurzu, S1
Jung, I1
Sugimura, H2
Stefan-van Staden, RI1
Yamada, H1
Natsume, H1
Iwashita, Y1
Szodorai, R1
Szederjesi, J1
Yari, D1
Ehsanbakhsh, Z1
Validad, MH1
Langroudi, FH1
Esfandiari, H1
Prager, A1
Hassanpour, K1
Kurup, SP1
Mets-Halgrimson, R1
Yoon, H1
Zeid, JL1
Mets, MB1
Rahmani, B1
Araujo-Castillo, RV1
Culquichicón, C1
Solis Condor, R1
Efendi, F1
Sebayang, SK1
Astutik, E1
Hadisuyatmana, S1
Has, EMM1
Kuswanto, H1
Foroutan, T1
Ahmadi, F1
Moayer, F1
Khalvati, S1
Zhang, Q2
Lyu, Y1
Huang, J1
Yu, N1
Wen, Z1
Hou, H1
Zhao, T1
Gupta, A1
Khosla, N1
Govindasamy, V1
Saini, A1
Annapurna, K1
Dhakate, SR1
Akkaya, Ö1
Chandgude, AL1
Dömling, A1
Harnett, J1
Oakes, K1
Carè, J1
Leach, M1
Brown, D1
Cramer, H1
Pinder, TA1
Steel, A1
Anheyer, D1
Cantu, J1
Valle, J1
Flores, K1
Gonzalez, D1
Valdes, C1
Lopez, J1
Padilla, V1
Alcoutlabi, M1
Parsons, J1
Núñez, K1
Hamed, M1
Fort, D1
Bruce, D1
Thevenot, P1
Cohen, A1
Weber, P1
Menezes, AMB1
Gonçalves, H1
Perez-Padilla, R1
Jarvis, D1
de Oliveira, PD1
Wehrmeister, FC1
Mir, S1
Wong, J1
Ryan, CM1
Bellingham, G1
Singh, M2
Waseem, R1
Eckert, DJ1
Chung, F1
Hegde, H1
Shimpi, N1
Panny, A1
Glurich, I1
Christie, P1
Acharya, A1
English, KL1
Downs, M1
Goetchius, E1
Buxton, R1
Ryder, JW1
Ploutz-Snyder, R1
Guilliams, M1
Scott, JM1
Ploutz-Snyder, LL1
Martens, C1
Goplen, FK1
Aasen, T1
Gjestad, R1
Nordfalk, KF1
Nordahl, SHG1
Inoue, T1
Soshi, S1
Kubota, M1
Marumo, K1
Mortensen, NP1
Caffaro, MM1
Patel, PR2
Uddin, MJ1
Aravamudhan, S1
Sumner, SJ1
Fennell, TR1
Gal, RL1
Cohen, NJ1
Kruger, D1
Beck, RW1
Bergenstal, RM1
Calhoun, P1
Cushman, T1
Haban, A1
Hood, K1
Johnson, ML1
McArthur, T1
Olson, BA1
Weinstock, RS1
Oser, SM1
Oser, TK1
Bugielski, B1
Strayer, H1
Aleppo, G1
Maruyama, H1
Hirayama, K1
Yamashita, M1
Ohgi, K1
Tsujimoto, R1
Takayasu, M1
Shimohata, H1
Kobayashi, M1
Buscagan, TM1
Rees, DC1
Jaborek, JR1
Zerby, HN1
Wick, MP1
Fluharty, FL1
Moeller, SJ1
Razavi, P1
Dickler, MN1
Shah, PD1
Toy, W1
Brown, DN1
Won, HH1
Li, BT1
Shen, R1
Vasan, N1
Modi, S1
Jhaveri, K1
Caravella, BA1
Patil, S1
Selenica, P1
Zamora, S1
Cowan, AM1
Comen, E1
Singh, A1
Covey, A1
Berger, MF1
Hudis, CA1
Norton, L1
Nagy, RJ1
Odegaard, JI1
Lanman, RB1
Solit, DB1
Robson, ME1
Lacouture, ME2
Brogi, E1
Reis-Filho, JS1
Moynahan, ME1
Scaltriti, M1
Chandarlapaty, S1
Papouskova, K1
Moravcova, M1
Masrati, G1
Ben-Tal, N1
Sychrova, H1
Zimmermannova, O1
Fang, J1
Fan, Y1
Luo, T2
Su, H1
Tsetseris, L1
Anthopoulos, TD1
Liu, SF1
Zhao, K1
Sacan, O1
Turkyilmaz, IB1
Bayrak, BB1
Mutlu, O1
Akev, N1
Yanardag, R1
Gruber, S1
Kamnoedboon, P1
Özcan, M1
Srinivasan, M1
Jo, YH1
Oh, HK1
Jeong, SY1
Lee, BG1
Zheng, J1
Guan, H1
Li, D2
Tan, H1
Maji, TK1
J R, A1
Mukherjee, S1
Alexander, R1
Mondal, A1
Das, S1
Sharma, RK1
Chakraborty, NK1
Dasgupta, K1
Sharma, AMR1
Hawaldar, R1
Pandey, M1
Naik, A1
Majumdar, K1
Pal, SK1
Adarsh, KV1
Ray, SK1
Karmakar, D1
Ma, Y2
Gao, W1
Ma, S1
Lin, W1
Zhou, T1
Wu, Q1
Ye, C1
He, X1
Jiang, F1
Yuan, D1
Chen, Q1
Hong, M1
Chen, K1
Hussain, M1
Razi, SS1
Yildiz, EA1
Zhao, J1
Yaglioglu, HG1
Donato, MD1
Jiang, J1
Jamil, MI1
Zhan, X1
Chen, F1
Cheng, D1
Wu, CT1
Utsunomiya, T2
Ichii, T1
Fujinami, S1
Nakajima, K1
Sanchez, DM1
Raucci, U1
Ferreras, KN1
Martínez, TJ1
Mordi, NA1
Mordi, IR1
Singh, JS1
McCrimmon, RJ1
Struthers, AD1
Lang, CC1
Wang, XW1
Yuan, LJ1
Yang, Y2
Chen, WF1
Luo, R1
Yang, K1
Amarasiri, SS1
Attanayake, AP1
Arawwawala, LDAM1
Jayatilaka, KAPW1
Mudduwa, LKB1
Ogunsuyi, O2
Akanni, O1
Alabi, O1
Alimba, C1
Adaramoye, O1
Cambier, S1
Eswara, S1
Gutleb, AC1
Bakare, A1
Gu, Z1
Cong, J1
Pellegrini, M1
Palmieri, S1
Ricci, A1
Serio, A1
Paparella, A1
Lo Sterzo, C1
Jadeja, SD1
Vaishnav, J1
Mansuri, MS1
Shah, C1
Mayatra, JM1
Shah, A1
Begum, R1
Song, H2
Lian, Y1
Wan, T1
Schultz-Lebahn, A1
Skipper, MT1
Hvas, AM1
Larsen, OH1
Hijazi, Z1
Granger, CB1
Hohnloser, SH1
Westerbergh, J1
Lindbäck, J1
Alexander, JH1
Keltai, M1
Parkhomenko, A1
López-Sendón, JL1
Lopes, RD1
Siegbahn, A1
Wallentin, L1
El-Tarabany, MS1
Saleh, AA1
El-Araby, IE1
El-Magd, MA1
van Ginkel, MPH1
Schijven, MP1
van Grevenstein, WMU1
Schreuder, HWR1
Pereira, EDM1
da Silva, J1
Carvalho, PDS1
Grivicich, I1
Picada, JN1
Salgado Júnior, IB1
Vasques, GJ1
Pereira, MADS1
Reginatto, FH1
Ferraz, ABF1
Vasilenko, EA1
Gorshkova, EN1
Astrakhantseva, IV1
Drutskaya, MS1
Tillib, SV1
Nedospasov, SA1
Mokhonov, VV1
Nam, YW1
Cui, M1
Orfali, R1
Viegas, A1
Nguyen, M1
Mohammed, EHM1
Zoghebi, KA1
Rahighi, S1
Parang, K1
Patterson, KC1
Kahanovitch, U1
Gonçalves, CM1
Hablitz, JJ1
Staruschenko, A1
Mulkey, DK1
Olsen, ML1
Gu, L1
Cao, X1
Mukhtar, A1
Wu, K1
Zhang, YY1
Zhu, Y1
Lu, DZ1
Dong, W1
Bi, WJ1
Feng, XJ1
Wen, LM1
Sun, H1
Qi, MC1
Chang, CC1
Dinh, TK1
Lee, YA1
Wang, FN1
Sung, YC1
Yu, PL1
Chiu, SC1
Shih, YC1
Wu, CY1
Huang, YD1
Lu, TT1
Wan, D1
Sakizadeh, J1
Cline, JP1
Snyder, MA1
Kiely, CJ1
McIntosh, S1
Jiang, X1
Cao, JW1
Zhao, CK1
Yang, R1
Zhang, QY1
Chen, KJ2
Liu, H3
He, Z1
Chen, B1
Wu, J1
Du, X1
Moore, J1
Blank, BR1
Eksterowicz, J1
Sutimantanapi, D1
Yuen, N1
Metzger, T1
Chan, B1
Huang, T1
Chen, X2
Duong, F1
Kong, W1
Chang, JH1
Sun, J1
Zavorotinskaya, T1
Ye, Q1
Junttila, MR1
Ndubaku, C1
Friedman, LS1
Fantin, VR1
Sun, D1
Fei, P1
Xie, Q1
Jiang, Y1
Feng, H1
Chang, Y2
Kang, H2
Xing, M1
Chen, J1
Shao, Z1
Yuan, C1
Wu, Y2
Allan, R1
Canham, K1
Wallace, R1
Singh, D1
Ward, J1
Cooper, A1
Newcomb, C1
Nammour, S1
El Mobadder, M1
Maalouf, E1
Namour, M1
Namour, A1
Rey, G1
Matamba, P1
Matys, J1
Zeinoun, T1
Grzech-Leśniak, K1
Segabinazi Peserico, C1
Garozi, L1
Zagatto, AM1
Machado, FA1
Hirth, JM1
Dinehart, EE1
Lin, YL1
Kuo, YF1
Nouri, SS1
Ritchie, C1
Volow, A1
Li, B2
McSpadden, S1
Dearman, K1
Kotwal, A1
Sudore, RL1
Ward, L1
Thakur, A1
Kondadasula, SV1
Ji, K1
Schalk, DL1
Bliemeister, E1
Ung, J1
Aboukameel, A1
Casarez, E1
Sloane, BF1
Lum, LG1
Xiao, M1
Feng, X1
Gao, R1
Du, B1
Brooks, T1
Zwirner, J1
Hammer, N1
Ondruschka, B1
Jermy, M1
Luengo, A1
Marzo, I1
Reback, M1
Daubit, IM1
Fernández-Moreira, V1
Metzler-Nolte, N1
Gimeno, MC1
Tonchev, I1
Heberman, D1
Peretz, A1
Medvedovsky, AT1
Gotsman, I1
Rashi, Y1
Poles, L1
Goland, S1
Perlman, GY1
Danenberg, HD1
Beeri, R1
Shuvy, M1
Fu, Q1
Yang, D1
Sarapulova, A1
Pang, Q1
Meng, Y1
Wei, L1
Ehrenberg, H1
Kim, CC1
Jeong, SH1
Oh, KH1
Nam, KT1
Sun, JY1
Ning, J1
Duan, Z1
Kershaw, SV1
Rogach, AL1
Gao, Z1
Wang, T1
Li, Q1
Cao, T1
Guo, L1
Fu, Y1
Seeger, ZL1
Izgorodina, EI1
Hue, S1
Beldi-Ferchiou, A1
Bendib, I1
Surenaud, M1
Fourati, S1
Frapard, T1
Rivoal, S1
Razazi, K1
Carteaux, G1
Delfau-Larue, MH1
Mekontso-Dessap, A1
Audureau, E1
de Prost, N1
Gao, SS1
Duangthip, D1
Lo, ECM1
Chu, CH1
Roberts, W1
Rosenheck, RA1
Miyake, T1
Kimoto, E1
Luo, L1
Mathialagan, S1
Horlbogen, LM1
Ramanathan, R1
Wood, LS1
Johnson, JG1
Le, VH1
Vourvahis, M1
Rodrigues, AD1
Muto, C1
Furihata, K1
Sugiyama, Y1
Kusuhara, H1
Gong, Q1
Song, W1
Sun, B1
Cao, P1
Gu, S1
Sun, X1
Zhou, G1
Toma, C1
Khandhar, S1
Zalewski, AM1
D'Auria, SJ1
Tu, TM1
Jaber, WA1
Cho, J2
Suwandaratne, NS1
Razek, S1
Choi, YH1
Piper, LFJ1
Watson, DF1
Banerjee, S1
Xie, S1
Lindsay, AP1
Bates, FS1
Lodge, TP1
Hao, Y1
Chapovetsky, A1
Liu, JJ1
Welborn, M1
Luna, JM1
Do, T1
Haiges, R1
Miller Iii, TF1
Marinescu, SC1
Lopez, SA1
Compter, I1
Eekers, DBP1
Hoeben, A1
Rouschop, KMA1
Reymen, B1
Ackermans, L1
Beckervordersantforth, J1
Bauer, NJC1
Anten, MM1
Wesseling, P1
Postma, AA1
De Ruysscher, D1
Lambin, P1
Qiang, L1
Yang, S1
Cui, YH1
He, YY1
Kumar, SK1
Jacobus, SJ1
Cohen, AD1
Weiss, M1
Callander, N1
Singh, AK1
Parker, TL1
Menter, A1
Parsons, B1
Kumar, P1
Kapoor, P1
Rosenberg, A1
Zonder, JA1
Faber, E1
Lonial, S1
Anderson, KC1
Richardson, PG1
Orlowski, RZ1
Wagner, LI1
Rajkumar, SV1
Li, G1
Hou, G1
Cui, J1
Xie, H1
Sun, Z1
Fang, Z1
Dunstand-Guzmán, E1
Hallal-Calleros, C1
Hernández-Velázquez, VM1
Canales-Vargas, EJ1
Domínguez-Roldan, R1
Pedernera, M1
Peña-Chora, G1
Flores-Pérez, I1
Kim, MJ1
Han, C1
White, K1
Park, HJ1
Ding, D1
Boyd, K1
Rothenberger, C1
Bose, U1
Carmichael, P1
Linser, PJ1
Tanokura, M1
Salvi, R1
Someya, S1
Samuni, A1
Goldstein, S1
Divya, KP1
Dharuman, V1
Feng, J2
Qian, Y1
Cheng, Q1
Ma, H1
Ren, X1
Wei, Q1
Pan, W1
Guo, J1
Situ, B1
An, T1
Zheng, L1
Augusto, S1
Ratola, N1
Tarín-Carrasco, P1
Jiménez-Guerrero, P1
Turco, M1
Schuhmacher, M1
Costa, S1
Teixeira, JP1
Costa, C1
Syed, A1
Marraiki, N1
Al-Rashed, S1
Elgorban, AM1
Yassin, MT1
Chankhanittha, T1
Nanan, S1
Sorokina, KN1
Samoylova, YV1
Gromov, NV1
Ogorodnikova, OL1
Parmon, VN1
Ye, J1
Liao, W1
Zhang, P1
Nabi, M1
Cai, Y1
Li, F1
Alsbou, EM1
Omari, KW1
Adeosun, WA1
Asiri, AM1
Marwani, HM1
Barral, M1
Jemal-Turki, A1
Beuvon, F1
Soyer, P1
Camparo, P1
Cornud, F1
Atwater, BD1
Jones, WS1
Loring, Z1
Friedman, DJ1
Namburath, M1
Papirio, S1
Moscariello, C1
Di Costanzo, N1
Pirozzi, F1
Alappat, BJ1
Sreekrishnan, TR1
Volpin, F1
Woo, YC1
Kim, H1
Freguia, S1
Jeong, N1
Choi, JS1
Phuntsho, S1
Shon, HK1
Domínguez-Zambrano, E1
Pedraza-Chaverri, J1
López-Santos, AL1
Medina-Campos, ON1
Cruz-Rivera, C1
Bueno-Hernández, F1
Espinosa-Cuevas, A1
Bulavaitė, A1
Dalgediene, I1
Michailoviene, V1
Pleckaityte, M1
Sauerbier, P1
Köhler, R1
Renner, G1
Militz, H1
Lee, YS1
Jung, YK1
Kim, JH1
Cho, SB1
Kim, DY1
Kim, MY1
Kim, HJ1
Seo, YS1
Yoon, KT1
Hong, YM1
Lee, JH2
Lee, HW1
Yim, HJ1
Jang, BK1
Jang, ES1
Jang, JY1
Hwang, SY1
Lee, YB1
Cho, EJ1
Yu, SJ1
Kim, YJ1
Yoon, JH1
Rolfs, F1
Piersma, SR1
Dias, MP1
Jonkers, J1
Jimenez, CR1
Yilmaz, S1
Tok, F1
Atalay-Sahar, E1
Kocyigit-Kaymakcioglu, B1
Ballar-Kırmızıbayrak, P1
Su, CL1
Tseng, CL1
Ramesh, C1
Liu, HS1
Huang, CF1
Yao, CF1
Zhang, W1
Xie, W1
Yu, W1
Shen, G1
Cao, Y1
Ding, W1
Gao, Q1
Cao, W1
Fang, L1
Du, R1
Lin, TY1
Ki, CS1
Lin, CC1
Ren, Z1
Zhu, K1
Lu, M1
Qu, Z1
Lu, L2
Song, T1
Zhou, W1
Yang, W1
Shi, L1
Bai, Y1
Guo, X1
Ye, SL2
Eldehna, WM1
Fares, M1
Ibrahim, HS1
Aly, MH1
Zada, S1
Ali, MM1
Abou-Seri, SM1
Abdel-Aziz, HA1
Abou El Ella, DA1
Negri, FV1
Porta, C1
Donato, MT1
Tolosa, L1
Gómez-Lechón, MJ1
Zhang, B1
Dong, S1
Cen, X1
Sun, ZP1
Shi, LH1
Zhang, XR1
Duan, Y1
Xu, WF1
Dai, G1
Wang, XJ1
Zhu, S1
Ran, J1
Yang, B1
Reilly, LM1
Gerami, P1
Guitart, J1
London, R1
Schulz, FM1
Giguère-Simmonds, PW1
Delriviere, L1
Chandraratana, H1
Hardy, K1
Zheng, S1
Olynyk, JK1
Yeoh, G1
Harm, S1
Stroble, K1
Hartmann, J1
Falkenhagen, D1
Nardulli, M1
Belviso, M1
Favia, P1
d'Agostino, R1
Gristina, R1
Dong, H1
Robertson, K1
Ko, YH1
Verhoeven, HA1
Lee, MJ1
Corbin, DJ1
Vogl, TJ1
Pedersen, PL1
Xing, B1
Yu, Y1
Gu, B1
Zhang, G1
Wei, D1
Gu, P1
Pender, C1
Goldfine, ID1
Manchem, VP1
Evans, JL1
Spevak, WR1
Shi, S1
Rao, S1
Bajjalieh, S1
Maddux, BA1
Youngren, JF1
Markowska, A1
Rózański, A1
Wołczyński, S1
Midura-Nowaczek, K1
Li, JN1
Song, DQ1
Lin, YH1
Hu, QY1
Yin, L1
Bekesi, G1
Holland, JF1
Jiang, JD1
BUTTLE, GA1
EPERON, J1
KAMESWARAN, L1
WEST, GB1
BLOEDOW, CE1
Mavri-Damelin, D2
Eaton, S2
Damelin, LH2
Rees, M2
Hodgson, HJ2
Selden, C2
Schäfer, C1
Hoffmann, L1
Heldt, K1
Lornejad-Schäfer, MR1
Brauers, G1
Gehrmann, T1
Garrow, TA1
Häussinger, D1
Mayatepek, E1
Schwahn, BC1
Schliess, F1
Peters, SJ1
Haagsman, HP1
van Norren, K1
Franke, WW1
Schiller, DL1
Hatzfeld, M1
Winter, S1
Brebnor, LD1
Grimm, J1
Balinsky, JB1
Danopoulos, ED3
Danopoulou, IE3
Kawada, M1
Nagamori, S1
Aizaki, H1
Fukaya, K1
Niiya, M1
Matsuura, T1
Sujino, H1
Hasumura, S1
Shimizu, K1
Yoshida, H1
Griffin, SJ1
O'Riordain, MG1
Fitzpatrick, JM1
Moynihan, JB1
Jurado, J1
Saparbaev, M1
Matray, TJ1
Greenberg, MM1
Laval, J1
Matthews, JM1
Hammacher, A1
Howlett, GJ1
Simpson, RJ1
David, P1
Viollon, C1
Alexandre, E1
Azimzadeh, A1
Nicod, L1
Wolf, P1
Jaeck, D1
Boudjema, K1
Richert, L1
Lester, EP1
Miller, JB1
Yachnin, S1
Ballal, NR1
Goldberg, DA1
Busch, H2
Stratman, FW1
Hochberg, AA1
Zahlten, RN1
Morris, HP3
Suzuki, H1
Iino, S1
Endo, Y1
Torii, M1
Miki, K1
Lawson, D1
Paik, WK1
Weinhouse, S1
Pausch, JG1
Keppler, DO1
Gerok, W1
Alpert, E1
Lea, MA1
Kock, MR1
Albrecht, C1
Van Zyl, IM1
Richardson, UI1
Snodgrass, PJ1
Nuzum, CT1
Tashjian, AH1
McLean, P1
Reid, E1
Gurney, MW1
Roth, JS1
Moloney, GE1
Higashi, K1
Rosenoer, VM1
Della Porta, G1
Rubenstein, B1
Frei, JV1
Terracini, B1
Testa, MC1
Rudali, G1
Matsuyama, A1
Tagashira, Y1
Nagata, C1
Gorbacheva, LB1
Kukushkina, GV1
Kuroda, Y1
Johnson, RB1
Ellingboe, K1
Gibbs, P1
Balhorn, R4
Bordwell, J1
Sellers, L1
Granner, D4
Chalkley, R4
Higashino, K3
Hashinotsume, M2
Yamamura, Y3
Kang, KY1
Takahashi, Y1
Oliver, D2
Hohmann, P1
Labadie, P1
Tatibana, M1
Shigesada, K1
Moyer, GH1
Pitot, HC1
Lin, JK1
Chen, YC1
Horng, SC1
Tung, TC1
Kudo, S1
Gronow, M1
Thackrah, TM1

Clinical Trials (3)

Trial Overview

TrialPhaseEnrollmentStudy TypeStart DateStatus
Re-validating Prophylactic Efficacy of Urea-based Cream on Sorafenib-induced Hand-foot Skin Reaction in Patients With Advanced Hepatocellular Carcinoma[NCT04568330]129 participants (Actual)Interventional2014-03-21Completed
18F-DCFPyL PET/CT in Hepatocellular Carcinoma[NCT05009979]Phase 250 participants (Anticipated)Interventional2023-01-18Recruiting
The Effect of Urea Cream on Sorafenib-associated Hand-Foot Skin Reaction in Patients With Korean Hepatocellular Carcinoma Patients: Multicenter, Prospective Randomized Double-Blind Controlled Study[NCT03212625]Phase 4288 participants (Actual)Interventional2016-01-28Completed
[information is prepared from clinicaltrials.gov, extracted Sep-2024]

Reviews

5 reviews available for urea and Hepatocellular Carcinoma

ArticleYear
Psychological distress among health care professionals of the three COVID-19 most affected Regions in Cameroon: Prevalence and associated factors.
    Annales medico-psychologiques, 2021, Volume: 179, Issue:2

    Topics: 3' Untranslated Regions; 5'-Nucleotidase; A549 Cells; Accidental Falls; Acetylcholinesterase; Acryli

2021
Aquaporins in Digestive System.
    Advances in experimental medicine and biology, 2017, Volume: 969

    Topics: Animals; Aquaporin 1; Biological Transport; Carcinoma, Hepatocellular; Cell Movement; Cell Prolifera

2017
Use of newborn and infant animals in carcinogenicity testing.
    Food and cosmetics toxicology, 1968, Volume: 6, Issue:2

    Topics: Age Factors; Animals; Animals, Newborn; Anthracenes; Carcinogens; Carcinoma, Hepatocellular; Hydroca

1968
[Abnormality in ontogeney and phylogeney in cancer cells with special reference to nitrogen metabolism].
    Tanpakushitsu kakusan koso. Protein, nucleic acid, enzyme, 1971, Volume: 16, Issue:11

    Topics: Animals; Biological Evolution; Carcinoma, Hepatocellular; DNA, Neoplasm; Glutaminase; Isoenzymes; Ki

1971
Two carbamyl phosphate synthetases of mammals: specific roles in control of pyrimidine and urea biosynthesis.
    Advances in enzyme regulation, 1972, Volume: 10

    Topics: Adenosine Triphosphate; Animals; Arginine; Aspartic Acid; Carbamates; Carbon Isotopes; Carcinoma, He

1972

Trials

5 trials available for urea and Hepatocellular Carcinoma

ArticleYear
Validation of the prophylactic efficacy of urea-based creams on sorafenib-induced hand-foot skin reaction in patients with advanced hepatocellular carcinoma: A randomised experiment study.
    Cancer reports (Hoboken, N.J.), 2022, Volume: 5, Issue:7

    Topics: Antineoplastic Agents; Carcinoma, Hepatocellular; Hand-Foot Syndrome; Humans; Liver Neoplasms; Niaci

2022
Functional Imaging of Liver Cancer (FLIC): Study protocol of a phase 2 trial of 18F-DCFPyL PET/CT imaging for patients with hepatocellular carcinoma.
    PloS one, 2022, Volume: 17, Issue:11

    Topics: Carcinoma, Hepatocellular; Clinical Trials, Phase II as Topic; Fluorodeoxyglucose F18; Humans; Liver

2022
Psychological distress among health care professionals of the three COVID-19 most affected Regions in Cameroon: Prevalence and associated factors.
    Annales medico-psychologiques, 2021, Volume: 179, Issue:2

    Topics: 3' Untranslated Regions; 5'-Nucleotidase; A549 Cells; Accidental Falls; Acetylcholinesterase; Acryli

2021
Effect of urea cream on sorafenib-associated hand-foot skin reaction in patients with hepatocellular carcinoma: A multicenter, randomised, double-blind controlled study.
    European journal of cancer (Oxford, England : 1990), 2020, Volume: 140

    Topics: Aged; Antineoplastic Agents; Carcinoma, Hepatocellular; Double-Blind Method; Female; Hand-Foot Syndr

2020
Randomized controlled trial of the prophylactic effect of urea-based cream on sorafenib-associated hand-foot skin reactions in patients with advanced hepatocellular carcinoma.
    Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 2015, Mar-10, Volume: 33, Issue:8

    Topics: Administration, Topical; Adult; Aged; Aged, 80 and over; Antineoplastic Agents; Carcinoma, Hepatocel

2015
Randomized controlled trial of the prophylactic effect of urea-based cream on sorafenib-associated hand-foot skin reactions in patients with advanced hepatocellular carcinoma.
    Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 2015, Mar-10, Volume: 33, Issue:8

    Topics: Administration, Topical; Adult; Aged; Aged, 80 and over; Antineoplastic Agents; Carcinoma, Hepatocel

2015
Randomized controlled trial of the prophylactic effect of urea-based cream on sorafenib-associated hand-foot skin reactions in patients with advanced hepatocellular carcinoma.
    Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 2015, Mar-10, Volume: 33, Issue:8

    Topics: Administration, Topical; Adult; Aged; Aged, 80 and over; Antineoplastic Agents; Carcinoma, Hepatocel

2015
Randomized controlled trial of the prophylactic effect of urea-based cream on sorafenib-associated hand-foot skin reactions in patients with advanced hepatocellular carcinoma.
    Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 2015, Mar-10, Volume: 33, Issue:8

    Topics: Administration, Topical; Adult; Aged; Aged, 80 and over; Antineoplastic Agents; Carcinoma, Hepatocel

2015

Other Studies

78 other studies available for urea and Hepatocellular Carcinoma

ArticleYear
U-shaped relationship between urea level and hepatic decompensation in chronic liver diseases.
    Clinical and molecular hepatology, 2022, Volume: 28, Issue:1

    Topics: Carcinoma, Hepatocellular; Elasticity Imaging Techniques; Humans; Liver Cirrhosis; Liver Failure; Li

2022
Determination of risk factors for fever after transarterial chemoembolization with drug-eluting beads for hepatocellular carcinoma.
    Medicine, 2021, Nov-05, Volume: 100, Issue:44

    Topics: Adult; Aged; Antineoplastic Agents; Carcinoma, Hepatocellular; Chemoembolization, Therapeutic; China

2021
Perfusion culture of multi-layered HepG2 hepatocellular carcinoma cells in a pressure-driven microphysiological system.
    Journal of bioscience and bioengineering, 2022, Volume: 134, Issue:4

    Topics: Albumins; Carcinoma, Hepatocellular; Cell Culture Techniques; Hep G2 Cells; Hepatocytes; Humans; Liv

2022
Deficiency of Carbamoyl Phosphate Synthetase 1 Engenders Radioresistance in Hepatocellular Carcinoma via Deubiquitinating c-Myc.
    International journal of radiation oncology, biology, physics, 2023, 04-01, Volume: 115, Issue:5

    Topics: Carbamoyl-Phosphate Synthase (Ammonia); Carbamoyl-Phosphate Synthase I Deficiency Disease; Carbamyl

2023
Deficiency of Carbamoyl Phosphate Synthetase 1 Engenders Radioresistance in Hepatocellular Carcinoma via Deubiquitinating c-Myc.
    International journal of radiation oncology, biology, physics, 2023, 04-01, Volume: 115, Issue:5

    Topics: Carbamoyl-Phosphate Synthase (Ammonia); Carbamoyl-Phosphate Synthase I Deficiency Disease; Carbamyl

2023
Deficiency of Carbamoyl Phosphate Synthetase 1 Engenders Radioresistance in Hepatocellular Carcinoma via Deubiquitinating c-Myc.
    International journal of radiation oncology, biology, physics, 2023, 04-01, Volume: 115, Issue:5

    Topics: Carbamoyl-Phosphate Synthase (Ammonia); Carbamoyl-Phosphate Synthase I Deficiency Disease; Carbamyl

2023
Deficiency of Carbamoyl Phosphate Synthetase 1 Engenders Radioresistance in Hepatocellular Carcinoma via Deubiquitinating c-Myc.
    International journal of radiation oncology, biology, physics, 2023, 04-01, Volume: 115, Issue:5

    Topics: Carbamoyl-Phosphate Synthase (Ammonia); Carbamoyl-Phosphate Synthase I Deficiency Disease; Carbamyl

2023
Deficiency of Carbamoyl Phosphate Synthetase 1 Engenders Radioresistance in Hepatocellular Carcinoma via Deubiquitinating c-Myc.
    International journal of radiation oncology, biology, physics, 2023, 04-01, Volume: 115, Issue:5

    Topics: Carbamoyl-Phosphate Synthase (Ammonia); Carbamoyl-Phosphate Synthase I Deficiency Disease; Carbamyl

2023
Deficiency of Carbamoyl Phosphate Synthetase 1 Engenders Radioresistance in Hepatocellular Carcinoma via Deubiquitinating c-Myc.
    International journal of radiation oncology, biology, physics, 2023, 04-01, Volume: 115, Issue:5

    Topics: Carbamoyl-Phosphate Synthase (Ammonia); Carbamoyl-Phosphate Synthase I Deficiency Disease; Carbamyl

2023
Deficiency of Carbamoyl Phosphate Synthetase 1 Engenders Radioresistance in Hepatocellular Carcinoma via Deubiquitinating c-Myc.
    International journal of radiation oncology, biology, physics, 2023, 04-01, Volume: 115, Issue:5

    Topics: Carbamoyl-Phosphate Synthase (Ammonia); Carbamoyl-Phosphate Synthase I Deficiency Disease; Carbamyl

2023
Deficiency of Carbamoyl Phosphate Synthetase 1 Engenders Radioresistance in Hepatocellular Carcinoma via Deubiquitinating c-Myc.
    International journal of radiation oncology, biology, physics, 2023, 04-01, Volume: 115, Issue:5

    Topics: Carbamoyl-Phosphate Synthase (Ammonia); Carbamoyl-Phosphate Synthase I Deficiency Disease; Carbamyl

2023
Deficiency of Carbamoyl Phosphate Synthetase 1 Engenders Radioresistance in Hepatocellular Carcinoma via Deubiquitinating c-Myc.
    International journal of radiation oncology, biology, physics, 2023, 04-01, Volume: 115, Issue:5

    Topics: Carbamoyl-Phosphate Synthase (Ammonia); Carbamoyl-Phosphate Synthase I Deficiency Disease; Carbamyl

2023
Transcriptome Analysis of Redox Systems and Polyamine Metabolic Pathway in Hepatoma and Non-Tumor Hepatocyte-like Cells.
    Biomolecules, 2023, 04-21, Volume: 13, Issue:4

    Topics: Carcinoma, Hepatocellular; Gene Expression Profiling; Hepatocytes; Humans; Liver Neoplasms; Metaboli

2023
The Effects of RKI-1447 in a Mouse Model of Nonalcoholic Fatty Liver Disease Induced by a High-Fat Diet and in HepG2 Human Hepatocellular Carcinoma Cells Treated with Oleic Acid.
    Medical science monitor : international medical journal of experimental and clinical research, 2020, Feb-06, Volume: 26

    Topics: Alanine Transaminase; Animals; Aspartate Aminotransferases; Carcinoma, Hepatocellular; Cholesterol;

2020
CKD-5, a novel pan-histone deacetylase inhibitor, synergistically enhances the efficacy of sorafenib for hepatocellular carcinoma.
    BMC cancer, 2020, Oct-15, Volume: 20, Issue:1

    Topics: Animals; Antineoplastic Agents; Carcinoma, Hepatocellular; Cell Differentiation; Cell Line, Tumor; C

2020
Feasibility of Phosphoproteomics on Leftover Samples After RNA Extraction With Guanidinium Thiocyanate.
    Molecular & cellular proteomics : MCP, 2021, Volume: 20

    Topics: Animals; Carcinoma, Hepatocellular; Cell Line; Chloroform; DNA Damage; Feasibility Studies; Guanidin

2021
Induction of Divergent Cell Death Pathways by Urea and Carbohydrazide Derivatives.
    Anti-cancer agents in medicinal chemistry, 2022, Volume: 22, Issue:9

    Topics: Antineoplastic Agents; Apoptosis; Carcinoma, Hepatocellular; Cell Line, Tumor; Endoplasmic Reticulum

2022
Using gene expression database to uncover biology functions of 1,4-disubstituted 1,2,3-triazole analogues synthesized via a copper (I)-catalyzed reaction.
    European journal of medicinal chemistry, 2017, May-26, Volume: 132

    Topics: Antineoplastic Agents; Apoptosis; Autophagy; Carcinoma, Hepatocellular; Cell Line, Tumor; Copper; Cu

2017
Tributyl phosphate impairs the urea cycle and alters liver pathology and metabolism in mice after short-term exposure based on a metabonomics study.
    The Science of the total environment, 2017, Dec-15, Volume: 603-604

    Topics: Animals; Aryl Hydrocarbon Hydroxylases; Carcinoma, Hepatocellular; Constitutive Androstane Receptor;

2017
Significant Down-Regulation of Urea Cycle Generates Clinically Relevant Proteomic Signature in Hepatocellular Carcinoma Patients with Macrovascular Invasion.
    Journal of proteome research, 2019, 05-03, Volume: 18, Issue:5

    Topics: Adult; Aged; Arginine; Blood Vessels; Carcinoma, Hepatocellular; Cholesterol; Fatty Acids; Female; G

2019
Manipulating hepatocellular carcinoma cell fate in orthogonally cross-linked hydrogels.
    Biomaterials, 2014, Volume: 35, Issue:25

    Topics: Carcinoma, Hepatocellular; Cell Dedifferentiation; Cell Line, Tumor; Cell Survival; Cells, Immobiliz

2014
Indoline ureas as potential anti-hepatocellular carcinoma agents targeting VEGFR-2: Synthesis, in vitro biological evaluation and molecular docking.
    European journal of medicinal chemistry, 2015, Jul-15, Volume: 100

    Topics: Antineoplastic Agents; Carcinoma, Hepatocellular; Cell Proliferation; Dose-Response Relationship, Dr

2015
Reply to F.V. Negri et al.
    Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 2015, Oct-01, Volume: 33, Issue:28

    Topics: Antineoplastic Agents; Carcinoma, Hepatocellular; Emulsions; Female; Hand-Foot Syndrome; Humans; Liv

2015
Urea-Based Cream to Prevent Sorafenib-Induced Hand-and-Foot Skin Reaction: Which Evidence?
    Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 2015, Oct-01, Volume: 33, Issue:28

    Topics: Antineoplastic Agents; Carcinoma, Hepatocellular; Emulsions; Female; Hand-Foot Syndrome; Humans; Liv

2015
Culture and Functional Characterization of Human Hepatoma HepG2 Cells.
    Methods in molecular biology (Clifton, N.J.), 2015, Volume: 1250

    Topics: Carcinoma, Hepatocellular; Cell Culture Techniques; Cytochrome P-450 Enzyme System; Glutathione Tran

2015
Targeting protein arginine methyltransferase 5 inhibits human hepatocellular carcinoma growth via the downregulation of beta-catenin.
    Journal of translational medicine, 2015, Nov-05, Volume: 13

    Topics: Animals; Apoptosis; beta Catenin; Carcinoma, Hepatocellular; Cell Cycle; Cell Line, Tumor; Cell Move

2015
Aminopeptidase N inhibitor 4cc synergizes antitumor effects of 5-fluorouracil on human liver cancer cells through ROS-dependent CD13 inhibition.
    Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie, 2015, Volume: 76

    Topics: Animals; Antineoplastic Combined Chemotherapy Protocols; Apoptosis; Carcinoma, Hepatocellular; CD13

2015
Hand foot skin reaction in cancer patients treated with the multikinase inhibitors sorafenib and sunitinib.
    Annals of oncology : official journal of the European Society for Medical Oncology, 2008, Volume: 19, Issue:11

    Topics: Administration, Topical; Aged; Aged, 80 and over; Antineoplastic Agents; Benzenesulfonates; Carcinom

2008
Human liver progenitor cell lines are readily established from non-tumorous tissue adjacent to hepatocellular carcinoma.
    Stem cells and development, 2010, Volume: 19, Issue:8

    Topics: AC133 Antigen; Adult Stem Cells; Animals; Antigens, CD; Antigens, Differentiation; Antigens, Neoplas

2010
Alginate-encapsulated human hepatoma C3A cells for use in a bioartificial liver device - the hybrid-MDS.
    The International journal of artificial organs, 2009, Volume: 32, Issue:11

    Topics: Albumins; Alginates; Carcinoma, Hepatocellular; Cell Line, Tumor; Cell Proliferation; Chromatography

2009
The study of specific and nonspecific hepatoma cells behavior by means of plasma-treated substrates.
    Journal of biomedical materials research. Part B, Applied biomaterials, 2010, Volume: 94, Issue:1

    Topics: Biocompatible Materials; Carcinoma, Hepatocellular; Cell Culture Techniques; Cell Differentiation; C

2010
DNA methylation suppresses expression of the urea cycle enzyme carbamoyl phosphate synthetase 1 (CPS1) in human hepatocellular carcinoma.
    The American journal of pathology, 2011, Volume: 178, Issue:2

    Topics: Carbamoyl-Phosphate Synthase (Ammonia); Carcinoma, Hepatocellular; Cell Line, Tumor; CpG Islands; DN

2011
A translational study "case report" on the small molecule "energy blocker" 3-bromopyruvate (3BP) as a potent anticancer agent: from bench side to bedside.
    Journal of bioenergetics and biomembranes, 2012, Volume: 44, Issue:1

    Topics: Adolescent; Ammonia; Antineoplastic Agents, Alkylating; Carcinoma, Hepatocellular; Energy Metabolism

2012
t-AUCB, an improved sEH inhibitor, suppresses human glioblastoma cell growth by activating NF-κB-p65.
    Journal of neuro-oncology, 2012, Volume: 108, Issue:3

    Topics: Apoptosis; Benzoates; Blotting, Western; Brain Neoplasms; Carcinoma, Hepatocellular; Cell Cycle; Cel

2012
Regulation of insulin receptor function by a small molecule insulin receptor activator.
    The Journal of biological chemistry, 2002, Nov-15, Volume: 277, Issue:46

    Topics: 3T3 Cells; Adipocytes; Animals; Biological Transport; Blotting, Western; Carcinoma, Hepatocellular;

2002
Synthesis and biological activity of carbocyclic lexitropsins with a bioreductive fragment.
    Farmaco (Societa chimica italiana : 1989), 2002, Volume: 57, Issue:12

    Topics: Antineoplastic Agents; Benzamides; Carcinoma, Hepatocellular; Cell Survival; Humans; Liver Neoplasms

2002
Inhibition of microtubule polymerization by 3-bromopropionylamino benzoylurea (JIMB01), a new cancericidal tubulin ligand.
    Biochemical pharmacology, 2003, May-15, Volume: 65, Issue:10

    Topics: Animals; Antineoplastic Agents; Apoptosis; Carcinoma, Hepatocellular; Cell Cycle; Cyclin B; Cyclin B

2003
Histamine formation and tumor growth.
    British journal of cancer, 1962, Volume: 16

    Topics: Animals; Carcinoma, Hepatocellular; Dihydroxyphenylalanine; Histamine; Liver Neoplasms; Liver Neopla

1962
PHASE II STUDIES OF HYDROXYUREA (NSC-32065) IN ADULTS: MISCELLANEOUS TUMORS.
    Cancer chemotherapy reports, 1964, Volume: 40

    Topics: Adenocarcinoma; Antineoplastic Agents; Carcinoma, Hepatocellular; Carcinoma, Squamous Cell; Carcinom

1964
Ornithine transcarbamylase and arginase I deficiency are responsible for diminished urea cycle function in the human hepatoblastoma cell line HepG2.
    The international journal of biochemistry & cell biology, 2007, Volume: 39, Issue:3

    Topics: Arginase; Base Sequence; Carcinoma, Hepatocellular; Cell Line, Tumor; DNA Primers; Gene Expression;

2007
Osmotic regulation of betaine homocysteine-S-methyltransferase expression in H4IIE rat hepatoma cells.
    American journal of physiology. Gastrointestinal and liver physiology, 2007, Volume: 292, Issue:4

    Topics: Animals; Betaine; Betaine-Homocysteine S-Methyltransferase; Carcinoma, Hepatocellular; Cell Line, Tu

2007
Cells for bioartificial liver devices: the human hepatoma-derived cell line C3A produces urea but does not detoxify ammonia.
    Biotechnology and bioengineering, 2008, Feb-15, Volume: 99, Issue:3

    Topics: Ammonia; Carcinoma, Hepatocellular; Cell Culture Techniques; Cell Line, Tumor; Humans; Liver, Artifi

2008
Arginase release by primary hepatocytes and liver slices results in rapid conversion of arginine to urea in cell culture media.
    Toxicology in vitro : an international journal published in association with BIBRA, 2008, Volume: 22, Issue:4

    Topics: Animals; Arginase; Arginine; Carcinoma, Hepatocellular; Cell Line, Tumor; Cell Survival; Cells, Cult

2008
Protein complexes of intermediate-sized filaments: melting of cytokeratin complexes in urea reveals different polypeptide separation characteristics.
    Proceedings of the National Academy of Sciences of the United States of America, 1983, Volume: 80, Issue:23

    Topics: Animals; Breast Neoplasms; Carcinoma, Hepatocellular; Cattle; Cell Line; Cytoskeleton; Electrophores

1983
Regulation of urea cycle enzymes in transplantable hepatomas and in the livers of tumor-bearing rats and humans.
    Cancer research, 1981, Volume: 41, Issue:7

    Topics: Animals; Betamethasone; Bucladesine; Carcinoma, Hepatocellular; Cell Line; Dietary Proteins; Enzyme

1981
Eleven years experience of oral urea treatment in liver malignancies.
    Clinical oncology, 1981, Volume: 7, Issue:4

    Topics: Adenocarcinoma; Administration, Oral; Adult; Aged; Carcinoma, Hepatocellular; Drug Administration Sc

1981
[A new liver support system composed of functional human cells and a radial-flow bioreactor].
    Human cell, 1994, Volume: 7, Issue:2

    Topics: Albumins; alpha-Fetoproteins; Ammonia; Artificial Organs; Carcinoma, Hepatocellular; Cells, Cultured

1994
Effects of dexamethasone and interleukin-6 on urea production by human hepatocytes in vitro.
    Biochemical Society transactions, 1997, Volume: 25, Issue:1

    Topics: Carcinoma, Hepatocellular; Cell Survival; Cells, Cultured; Dexamethasone; Humans; Interleukin-6; Kin

1997
The ring fragmentation product of thymidine C5-hydrate when present in DNA is repaired by the Escherichia coli Fpg and Nth proteins.
    Biochemistry, 1998, May-26, Volume: 37, Issue:21

    Topics: Bacterial Proteins; Base Composition; Carcinoma, Hepatocellular; Cell Extracts; Deoxyribonuclease (P

1998
Physicochemical characterization of an antagonistic human interleukin-6 dimer.
    Biochemistry, 1998, Jul-28, Volume: 37, Issue:30

    Topics: Carcinoma, Hepatocellular; Chemical Phenomena; Chemistry, Physical; Circular Dichroism; Dimerization

1998
Metabolic capacities in cultured human hepatocytes obtained by a new isolating procedure from non-wedge small liver biopsies.
    Human & experimental toxicology, 1998, Volume: 17, Issue:10

    Topics: Adult; Aged; Aged, 80 and over; Albumins; Biopsy; Blotting, Western; Carcinoma, Hepatocellular; Cell

1998
Heterogeneity of human alpha-fetoprotein as revealed by isoelectric focusing in urea-containing gels.
    Biochimica et biophysica acta, 1978, Sep-26, Volume: 536, Issue:1

    Topics: alpha-Fetoproteins; Carcinoma, Hepatocellular; Electrophoresis, Polyacrylamide Gel; Genetic Variatio

1978
Dissociation and reconstitution of chromatin without appreciable degradation of the proteins.
    Biochemical and biophysical research communications, 1975, Feb-17, Volume: 62, Issue:4

    Topics: Animals; Carcinoma, Hepatocellular; Chromatin; DNA-Directed RNA Polymerases; Electrophoresis, Polyac

1975
Sulfhydryl group quantitation of hepatoma and liver microsomal fractions.
    Cancer research, 1975, Volume: 35, Issue:6

    Topics: Age Factors; Animals; Carcinoma, Hepatocellular; Cell Fractionation; Disulfides; Edetic Acid; Endopl

1975
Tumor-specific alkaline phosphatase in hepatoma.
    Annals of the New York Academy of Sciences, 1975, Aug-22, Volume: 259

    Topics: Adult; Alkaline Phosphatase; Carcinoma, Hepatocellular; Edetic Acid; Female; Fetus; Humans; Imidazol

1975
The results of urea-treatment in liver maligancies.
    Clinical oncology, 1975, Volume: 1, Issue:4

    Topics: Administration, Oral; Adult; Aged; Carcinoma, Hepatocellular; Female; Humans; Liver Neoplasms; Male;

1975
Urea synthesis in Novikoff and Morris hepatomas.
    Cancer research, 1977, Volume: 37, Issue:3

    Topics: Animals; Carbamoyl-Phosphate Synthase (Ammonia); Carcinoma, Hepatocellular; Fasting; Liver; Liver Ne

1977
Increased de novo pyrimidine nucleotide synthesis in liver induced by ammonium ions in amounts surpassing the urea cycle capacity.
    European journal of biochemistry, 1977, Jun-01, Volume: 76, Issue:1

    Topics: Animals; Azauridine; Carbamoyl-Phosphate Synthase (Ammonia); Carbamoyl-Phosphate Synthase (Glutamine

1977
Characterization and subunit analysis of ferritin isolated from normal and malignant human liver.
    Cancer research, 1975, Volume: 35, Issue:6

    Topics: Carcinoma, Hepatocellular; Chemical Phenomena; Chemistry; Chromatography, Gel; Electrophoresis, Poly

1975
Nuclear protein changes in rat hepatomas correlating with growth rate.
    Cancer research, 1975, Volume: 35, Issue:7

    Topics: Acetates; Animals; Carcinoma, Hepatocellular; Chick Embryo; Densitometry; Electrophoresis, Polyacryl

1975
A comparative study of the protein components of ribonucleoprotein particles isolated from rat liver and hepatoma nuclei.
    Experimental cell research, 1973, Volume: 76, Issue:1

    Topics: Animals; Carcinoma, Hepatocellular; Cell Nucleus; Electrophoresis, Polyacrylamide Gel; Liver; Liver

1973
Letter: Regression of liver cancer with oral urea.
    Lancet (London, England), 1974, Jan-26, Volume: 1, Issue:7848

    Topics: Administration, Oral; Aged; Carcinoma, Hepatocellular; Female; Humans; Liver Neoplasms; Male; Middle

1974
Establishment of a clonal strain of hepatoma cells which maintain in culture the five enzymes of the urea cycle.
    Journal of cellular physiology, 1974, Volume: 83, Issue:1

    Topics: Ammonia; Animals; Arginase; Arginine; Bucladesine; Carbamates; Carcinoma, Hepatocellular; Chromosome

1974
Effect of azo-dye carcinogenesis on enzymes concerned with urea synthesis in rat liver.
    The Biochemical journal, 1964, Volume: 91, Issue:3

    Topics: Animals; Arginase; Carcinogens; Carcinoma, Hepatocellular; Glucosephosphate Dehydrogenase; Ligases;

1964
Studies on the function of intracellular ribonucleases. V. Ribonuclease activity in ribosomes and polysomes prepared from rat liver and hepatomas.
    The Journal of cell biology, 1966, Volume: 29, Issue:3

    Topics: Animals; Carcinoma, Hepatocellular; Centrifugation, Density Gradient; Edetic Acid; Hydrogen-Ion Conc

1966
Subtotal hepatectomy for primary hepatic carcinoma.
    British medical journal, 1967, Jun-24, Volume: 2, Issue:5555

    Topics: Adolescent; Bilirubin; Carcinoma, Hepatocellular; Cholestasis; Female; Hepatectomy; Humans; Liver Ab

1967
Stability of nucleolar 45-S RNA.
    Biochimica et biophysica acta, 1967, Mar-29, Volume: 138, Issue:1

    Topics: Animals; Carcinoma, Hepatocellular; Cell Nucleolus; Centrifugation, Density Gradient; Hydrogen-Ion C

1967
Investigation of albumin metabolism in man.
    Proceedings of the Royal Society of Medicine, 1967, Nov-01, Volume: 60, Issue:11 Part 1

    Topics: Amino Acids; Carbon Isotopes; Carcinoma, Hepatocellular; Celiac Disease; Humans; Hypertension; Liver

1967
(Mg2+ Na+ K+)-ATPase activity of liver from tumor bearing rats.
    Biochimica et biophysica acta, 1969, Volume: 191, Issue:3

    Topics: Adenosine Triphosphatases; Animals; Binding Sites; Carcinoma, Hepatocellular; Enzyme Activation; Hyd

1969
Toxicity, tissue changes, and tumor induction in inbred Swiss mice by methylnitrosamine and -amide compounds.
    Cancer research, 1970, Volume: 30, Issue:1

    Topics: Adenoma; Animals; Animals, Newborn; Blood Cell Count; Bone Marrow; Bone Marrow Cells; Carcinoma, Hep

1970
Carcinogenicity of a single administration of N-nitrosomethylurea: a comparison between newborn and 5-week-old mice and rats.
    British journal of cancer, 1970, Volume: 24, Issue:3

    Topics: Adenoma; Animals; Animals, Newborn; Carcinogens; Carcinoma, Hepatocellular; Female; Gastrointestinal

1970
[The cancer-risk in man from synthetic sweetening agents].
    La Presse medicale, 1971, Mar-13, Volume: 79, Issue:13

    Topics: Animals; Carcinoma, Hepatocellular; Cyclamates; Female; Liver Neoplasms; Lung Neoplasms; Lymphoma, N

1971
A circular dichroism study on the conformation of DNA in rat liver chromatin.
    Biochimica et biophysica acta, 1971, Jun-30, Volume: 240, Issue:2

    Topics: Animals; Ascitic Fluid; Carcinoma, Hepatocellular; Cell Line; Chemical Phenomena; Chemistry; Chromos

1971
Some aspects of the mechanism of action of 1-propyl-1-nitrosourea.
    Biochemical pharmacology, 1970, Volume: 19, Issue:5

    Topics: Amino Acids; Animals; Arginine; Carbon Isotopes; Carcinoma, Ehrlich Tumor; Carcinoma, Hepatocellular

1970
A study of various electrophoretic and inhibition techniques for separating serum alkaline phosphatase isoenzymes.
    Clinical chemistry, 1972, Volume: 18, Issue:2

    Topics: Acrylamides; Alkaline Phosphatase; Bile; Bone and Bones; Buffers; Carcinoma, Hepatocellular; Clinica

1972
Histone phosphorylation and DNA synthesis are linked in synchronous cultures of HTC cells.
    Biochemical and biophysical research communications, 1972, Feb-16, Volume: 46, Issue:3

    Topics: Benzocycloheptenes; Carcinoma, Hepatocellular; Cell Line; Cells, Cultured; DNA; Electrophoresis; His

1972
Lysine-rich histone phosphorylation. A positive correlation with cell replication.
    Biochemistry, 1972, Mar-14, Volume: 11, Issue:6

    Topics: Alkaline Phosphatase; Animals; Carcinoma, Hepatocellular; Cell Division; Cell Line; Densitometry; El

1972
Effect of neuraminic acid removal on the properties of a variant alkaline phosphatase in hepatoma.
    Clinica chimica acta; international journal of clinical chemistry, 1972, Volume: 40, Issue:1

    Topics: Alkaline Phosphatase; Aminocaproates; Carcinoma, Hepatocellular; Edetic Acid; Enzyme Activation; Gen

1972
Studies on a variant alkaline phosphatase in sera of patients with hepatocellular carcinoma.
    Clinica chimica acta; international journal of clinical chemistry, 1972, Volume: 40, Issue:1

    Topics: Acrylamides; Alkaline Phosphatase; Amino Acids; Animals; Antibody Specificity; Carcinoma, Hepatocell

1972
Turnover of deoxyribonucleic acid, histones, and lysine-rich histone phosphate in hepatoma tissue culture cells.
    Biochemistry, 1972, Oct-10, Volume: 11, Issue:21

    Topics: Carcinoma, Hepatocellular; Cell Line; DNA, Neoplasm; Electrophoresis, Polyacrylamide Gel; Half-Life;

1972
Molecular nature of F 1 histone phosphorylation in cultured hepatoma cells.
    Biochemistry, 1972, Oct-10, Volume: 11, Issue:21

    Topics: Carcinoma, Hepatocellular; Cell Line; Electrophoresis, Polyacrylamide Gel; Histones; Isotope Labelin

1972
[Ornithine-carbamoyl-transferase and its clinical valve].
    La Revue du praticien, 1972, Apr-21, Volume: 22, Issue:12

    Topics: Ammonia; Carbon Dioxide; Carcinoma, Hepatocellular; Clinical Enzyme Tests; Hepatitis A; Jaundice; Li

1972
Protein turnover in microsomal subfractions of liver and Morris hepatomas 7800 and 9618A.
    Cancer research, 1973, Volume: 33, Issue:6

    Topics: Animals; Carbon Isotopes; Carcinoma, Hepatocellular; Centrifugation, Density Gradient; Cholesterol;

1973
Inhibition of urea on the hepatocarcinogensis induced by N, N-dimethyl-4-aminoazobenzene in rats.
    Taiwan yi xue hui za zhi. Journal of the Formosan Medical Association, 1973, Volume: 72, Issue:5

    Topics: Animals; Carcinoma, Hepatocellular; Female; Liver Neoplasms; p-Dimethylaminoazobenzene; Rats; Urea

1973
Further investigation of a variant of the placental alkaline phosphatase in human hepatic carcinoma.
    Cancer research, 1974, Volume: 34, Issue:12

    Topics: Alkaline Phosphatase; Animals; Carcinoma, Hepatocellular; Chromatography, Gel; Cross Reactions; Edet

1974
Nuclear protein changes during the nitrosamine-induced carcinogenesis of rat liver.
    Chemico-biological interactions, 1974, Volume: 9, Issue:3

    Topics: Animals; Binding Sites; Carbon Radioisotopes; Carcinogens; Carcinoma, Hepatocellular; Cell Nucleus;

1974